Semaglutide Weight Management and Cardiovascular Risk Reduction slide image

Semaglutide Weight Management and Cardiovascular Risk Reduction

Today's speakers Martin Holst Lange Executive Vice President and Head of Development Stephen Charles Langford Gough Senior Vice President and Global Chief Medical Officer
View entire presentation